​

Titan Pharmaceuticals Ownership | Who Owns Titan Pharmaceuticals?

OverviewForecastFinancialsChart

Titan Pharmaceuticals Ownership Summary

Titan Pharmaceuticals is owned by 1.61% institutional investors, 42.79% insiders, and 55.60% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.48% of its assets in Titan Pharmaceuticals shares.

TTNP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTitan Pharmaceuticals1.61%42.79%55.60%
SectorHealthcare Stocks 279.18%10.62%-189.80%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20251721.43%14,708410.69%11567.76%7600.00%1-66.67%
Dec 31, 202414-6.67%2,880-82.86%-9.48%1-75.00%3-
Sep 30, 202415-11.76%16,798-47.82%114.82%433.33%--100.00%
Jun 30, 2024176.25%32,1900.22%324.84%3-40.00%1-90.00%
Mar 31, 202416-27.27%32,118-96.81%39.08%525.00%1042.86%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index4.42K0.48%1.30K
Vanguard Institutional Extnd Mkt Idx Tr4.10K0.45%-
Fidelity Nasdaq Composite Index2.47K0.27%-
Fidelity Series Total Market Index985.000.11%137.00
NT Ext Equity Mkt Idx Fd - L293.000.03%-
Northern Trust Extended Eq Market Idx293.000.03%-
NT Ext Equity Mkt Idx Fd - NL161.000.02%-
State St US Extended Mkt Indx NL Cl C155.000.02%-
SSgA U.S. Extended Market Index Class I3.10K0.02%-
NT Ext Equity Mkt Idx Fd - DC - NL - T2125.000.01%-2.00

Recent Insider Transactions

DateNameRoleActivityValue
Jun 21, 2023Lazar David E. Chief Executive OfficerSell$441.65K
Jun 21, 2023Lazar David E. Chief Executive OfficerSell$441.65K
Jan 25, 2023Lazar David E. Chief Executive OfficerBuy$20.07K
Jan 24, 2023Lazar David E. Chief Executive OfficerBuy$36.22K
Jul 06, 2022Activist Investing LLC Buy$739.01K

Insider Transactions Trends

DateBuySell
2023 Q4--
2023 Q3--
2023 Q2-2
2023 Q12-
2022 Q31-

TTNP Ownership FAQ

Who Owns Titan Pharmaceuticals?

Titan Pharmaceuticals shareholders are primarily institutional investors at 1.61%, followed by 42.79% insiders and 55.60% retail investors. The average institutional ownership in Titan Pharmaceuticals's industry, Biotech Stocks , is 63.96%, which Titan Pharmaceuticals falls below.

Does Blackrock own Titan Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Titan Pharmaceuticals.

Who is the top mutual fund holder of Titan Pharmaceuticals shares?

Fidelity Extended Market Index is the top mutual fund holder of Titan Pharmaceuticals shares, with 0.48% of its total shares outstanding invested in 4.42K Titan Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools